Akturk HK, et al. - In this study, researchers assessed the risk for diabetic ketoacidosis (DKA) in relation to cannabis use among adults with type 1 diabetes (T1D), and reported on findings of recurrent DKA in association with cannabis use in patients with T1D.

• With changes in legality and public perception in the United States, use of cannabis is increasing.
• Studies have reported improved insulin sensitivity and pancreatic beta cell function with cannabis use.
• Cannabis has been suggested as a potential therapeutic agent for the treatment of type 2 diabetes.